Analytical Procedures and Methods Validation for Drugs and Biologics
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 27, 2015
April 21, 2020
09d35164-7a70-4359-b2bc-338524a3d23c
Related Documents
Allowable Excess Volume and Labeled Vial Fill Size in Injectable Drug and Biological Products
Guidance DocumentJune 25, 2015Center for Drug Evaluation and Research
Patient Counseling Information Section of Labeling for Human Prescription Drug and Biological Products — Content and Format
Guidance DocumentDecember 10, 2014Center for Drug Evaluation and Research
E2C(R2) Periodic Benefit-Risk Evaluation Report – Questions and Answers
Guidance DocumentJuly 19, 2016Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.